News Search results: Bayer designation
The FDA has granted qualified infectious disease product (QIDP) designation to two Bayer investigational agents, Amikacin Inhale and Ciprofloxacin
RT Magazine · Nov. 25, 2014
Related News
The U.S. Food and Drug Administration (FDA) has granted qualified infectious disease product (QIDP) designation to two Bayer investigational agents,
Big News Network · Nov. 25, 2014
... designation to two Bayer investigational agents, Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation (DPI).  The QIDP designation...
TheStreet.com · Nov. 24, 2014
Administration (FDA) has granted Breakthrough Therapy designation to ... including Regeneron's agreements with Sanofi and Bayer HealthCare LLC, to
Yahoo! Finance · Nov. 19, 2014  Explore story »
... leadership in clinical and research functions at Bayer Consumer Care ... COR-003 (levoketoconazole) has received orphan designation from both ...
Morningstar.com · Nov. 19, 2014  Explore story »